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Introduction
Lipid droplets (LDs) are ubiquitous organelles that collect, 
store, and supply lipids (Walther and Farese, 2012). Nonethe-
less, excessive or reduced accumulations of LDs are hallmarks 
of prevalent human diseases including steatohepatitis, obesity, 
diabetes, myopathies, arteriosclerosis, or lipodystrophies. How-
ever, relatively little is known about the molecular processes 
and sites that control LD formation. In eukaryotes, LDs likely 
form de novo by accumulation of neutral lipids in the ER. Con-
sistent with this, the ER harbors enzymes required for neutral 
lipid synthesis (Buhman et al., 2001), many ER proteins are re-
quired for LD formation and expansion (Brasaemle and Wolins, 
2012), LDs can be generated in vitro with ER microsomes 
(Lacey et al., 1999; Marchesan et al., 2003), and there exists 
an active partitioning of proteins between the ER and LDs 
(Jacquier et al., 2011). However, although it has been possible 
to detect early LDs in the proximity of the ER (Pol et al., 2004; 
Wolins et al., 2005; Turró et al., 2006; Kuerschner et al., 2008; 
Skinner et al., 2009; Poppelreuther et al., 2012), whether these 
are indeed nascent LDs, and whether specialized microdomains 
existed before the recruitment of these proteins was unknown. 
Indeed, it was commonly assumed that direct imaging of newly 
forming LDs was impossible with the current methodology 
(Salo et al., 2011; Suzuki et al., 2011).
The generally accepted model is that triglycerides are 
deposited as a lens within the ER bilayer. This process is 
presumably regulated by proteins, as LD formation is not 
spontaneously triggered by accumulation of neutral lipids in 
the ER (Gubern et al., 2008; Adeyo et al., 2011). Thus, ER 
proteins that can extend hydrophobic domains into the bi-
layer are attractive candidates to recognize and organize the 
sites of nucleation. We previously identified a localization 
signal for sorting proteins with a hydrophobic domain within 
Control of lipid droplet (LD) nucleation and copy number are critical, yet poorly understood, pro-cesses. We use model peptides that shift from the 
endoplasmic reticulum (ER) to LDs in response to fatty 
acids to characterize the initial steps of LD formation 
occurring in lipid-starved cells. Initially, arriving lipids 
are rapidly packed in LDs that are resistant to starvation 
(pre-LDs). Pre-LDs are restricted ER microdomains with 
a stable core of neutral lipids. Subsequently, a first round 
of “emerging” LDs is nucleated, providing additional 
lipid storage capacity. Finally, in proportion to lipid 
concentration, new rounds of LDs progressively assemble. 
Confocal microscopy and electron tomography suggest 
that emerging LDs are nucleated in a limited number of 
ER microdomains after a synchronized stepwise process 
of protein gathering, lipid packaging, and recognition 
by Plin3 and Plin2. A comparative analysis demon-
strates that the acyl-CoA synthetase 3 is recruited early 
to the assembly sites, where it is required for efficient LD 
nucleation and lipid storage.
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Results
HPos but not HNeu is transported from 
the ER into LDs after lipid loading
A model peptide (HPos) was generated by fusion of the hydro-
phobic domain of ALDI with the last 20 residues of caveolin-1 
(Fig. 1 A). This caveolin-1 sequence has an isoelectric point of 
9.0 and targets caveolin-1 to LDs (Ingelmo-Torres et al., 2009). 
As a negative control, we mutated to glycines the three positive 
residues in the positive sequence (Fig. 1 A, bold letters). The re-
sulting peptide (HNeu) accumulates on the ER but is excluded 
from LDs (Fig. 1). The peptides were N-terminally tagged with 
fluorescent molecules (GFP or orange fluorescent protein [OFP]). 
For these microscopy-based studies, we selected COS-1 cells, 
commonly used to study trafficking of proteins within the ER 
(Lippincott-Schwartz et al., 2001).
Initially, cells were transfected with GFP-HPos or GFP-
HNeu for 24 h in the absence of serum to reduce extracellular 
lipids and LDs (referred to as starvation). After starvation, cells 
were fractionated in sucrose density gradients, and there was no 
visible LD fraction (Fig. 1 B and Nile red in Fig. 8 G). HPos 
and HNeu were present in the same fraction as the endogenous 
ER marker Sec61. Endogenous Plin2 was in the bottom of the 
the ER into LDs (Ingelmo-Torres et al., 2009). The signal 
includes the hydrophobic residues for initial association with 
the ER, and a sequence enriched in positive amino acids for 
subsequent targeting into LDs. One class of proteins with 
endogenous sorting signals of this type are caveolins (Pol 
et al., 2004), scaffolding molecules that organize specific 
lipids in different membranes (Bosch et al., 2011) and are re-
quired for efficient LD formation (Fernández-Rojo et al., 
2012). However, caveolins dynamically associate with LDs 
and traffic between the ER, LDs, the Golgi complex, endo-
somes, and the plasma membrane (Pol et al., 2005; Le Lay 
et al., 2006). A second group of proteins interacting with 
LDs by hydrophobic domains includes the methyl transfer-
ases ALDI, AAM-B, and Erg6. In contrast to caveolins, these 
proteins shift exclusively between the ER and LDs (Turró 
et al., 2006; Zehmer et al., 2008; Jacquier et al., 2011). Be-
cause such endogenous proteins potentially have additional 
interactions and functions, we have generated here a minimal 
model peptide by fusion of the hydrophobic domain of ALDI 
in order to anchor the peptide to the ER, and the LD targeting 
signal of caveolin-1, for sorting the peptide within the ER 
into LDs. This model peptide has a high affinity for LDs and 
has been used as a marker for LDs and related domains.
Figure 1. ER into LD segregation of HPos. (A) Model peptides used in this work. Bold letters indicate the three positive residues that were mutated to 
glycines. (B) Starved GFP-HPos– or GFP-HNeu–transfected cells (24 h stv) and cells additionally incubated 24 h with OA (24 h OA) were fractionated in 
sucrose density gradients. The distribution of the peptides in the gradients was analyzed by Western blotting with anti-GFP antibodies. Each panel shown 
represents a separate gradient. The figure also includes representative fractionations in separate gradients of an ER resident protein (Sec61) and a LD pro-
tein (Plin2) detected with specific antibodies. (C–F) Distribution of GFP-HNeu and GFP-HPos in starved cells (C and D) or OA-loaded cells (E and F). Bottom 
panels show high-magnification areas selected from the corresponding panels on top. Arrows in D indicate pre-LDs. Bars: (top) 20 µm; (bottom) 2 µm.
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Lipid arrival promotes rapid segregation of 
HPos within the ER into LDs
To investigate the LD nucleation sites, we incubated starved 
HPos-transfected cells with OA for short times. After 7.5 min, 
HPos had already accumulated in rounded structures consis-
tently connected to the ER (Fig. 2 A). In cotransfected cells, 
OFP-HPos and GFP-HNeu did not colocalize in these structures 
(Fig. 2 B), which suggests that they are early LDs. Critically, 
HPos did not modify the initial stages of LD formation. When 
starved cells were loaded with OA for 30 min, formation of 
Nile red–positive LDs was indistinguishable between non-
transfected and transfected cells (Fig. 2 C). Further, HPos did 
not modify the recruitment of endogenous proteins, such as 
Plin3, in the newly-formed LDs (Fig. 2 D).
We next examined the process with higher temporal reso-
lution using time-lapse confocal microscopy. In these experi-
ments, starved HPos-transfected cells were additionally treated 
with cycloheximide to reduce the pool of newly synthesized 
protein, and cells were selected for the labeling of well-defined 
ER elements. As described above, several HPos-positive struc-
tures were present before OA addition (Fig. 3 A, white circles 
gradient, which is consistent with a cytosolic distribution in 
the absence of LDs. Confocal microscopy confirmed that the 
peptides accumulated in the nuclear envelope, in central ER 
sheet-like structures, and in tubules arranged in triple junction 
polygons forming the branching ER network (Fig. 1, C and D). 
Electron microscopy analysis confirmed that both markers were 
completely restricted to the ER (unpublished data). Identical 
results were obtained when transfected cells were incubated 
for 24 h in a medium containing 5% of a delipidated FCS (un-
published data).
Next, starved HPos- and HNeu-transfected cells were 
treated for 24 h with 175 µg/ml of oleic acid (OA) to induce LD 
formation. The fractionation demonstrated the existence of a 
LD fraction, enriched for Plin2 and HPos but not for HNeu 
(Fig. 1 B). Confocal microscopy confirmed that HPos was on 
LDs (Fig. 1 F) and that HNeu remained in the ER (Fig. 1 E). Thus, 
HPos follows an OA-promoted transport pathway between the 
ER and LDs. In addition to being found in the ER tubules of the 
starved cells, HPos, but not HNeu, was found in small punctate 
structures apparently connected to the ER (Fig. 1 D, arrows) 
even though mature LDs were not visible in that cell.
Figure 2. Segregation of HPos into LD after lipid arrival. (A) Starved GFP-HPos–transfected cells were treated with OA for 7.5 min and analyzed by 
microscopy. (B) Starved OFP-HPos– and GFP-HNeu–cotransfected cells were loaded with OA for 7.5 min and analyzed by microscopy. The inset shows 
a high-magnification detail of an emerging LD. (C and D) Starved GFP-HPos–transfected cells were loaded with OA for 30 min. The distribution of neutral 
lipids was detected with Nile red (red in C), and the distribution of endogenous Plin3 was detected with antibodies (red in D). Asterisks indicate transfected 
cells. Bars: (A, C, and D) 20 µm; (B, main panel) 2 µm; (B, inset) 0.5 µm.
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black circles), and for emerging LDs there was a roughly 5-min 
delay between OA addition and visible HPos accumulation 
(Fig. 3 B, red circles). At the end of the video, 15 min after OA 
addition, Nile red labeled the emerging LDs (Fig. 3 D, bottom), 
which indicates that these sites are bona fide LDs. Similar to 
caveolins recruited to LDs from the ER (Pol et al., 2004), but in 
contrast to Plin2 (Soni et al., 2009), preincubation with brefeldin 
A for 15 min before the addition of OA did not modify the 
accumulation of HPos in emerging LDs (unpublished data), 
which suggests that this peptide is not transported via vesicular 
in -5 panel; and Video 1). These structures were apparently 
stable in the ER. Because these structures exclude HNeu (see 
Fig. 8), contain a core of neutral lipids (Fig. 3 D), and were 
observed before the OA addition, we denote these as “pre-
existing LDs” (pre-LDs).
Once OA was added (+OA in Fig. 3 A and Video 1), addi-
tional HPos-positive structures appeared in 5–7 min (Fig. 3 A, 
red circles), and we denote these as “emerging LDs.” The treat-
ment with OA caused accumulation of HPos into the puncta. 
For pre-LDs, HPos was incorporated within 30–60 s (Fig. 3 B, 
Figure 3. Dynamics of HPos incorporation into emerging LDs. (A) Starved GFP-HPos–transfected cells were analyzed by video microscopy (Video 1). 
Pre-LDs (white circles) were followed for 5 min and then cells were loaded with OA (+OA). Red circles indicate LDs emerging after 5 or 9 min. Bar, 2 µm. 
(B) Quantification of HPos fluorescence intensity and size of pre-LDs (black circles) and emerging LDs (red circles) in three independent experiments as in A. 
(C) Starved GFP-HPos–transfected cells were treated with increasing OA concentrations for 15 min. Cells were fixed and the sizes and numbers of emerg-
ing LDs were quantified. **, P < 0.01; ***, P < 0.001. (D) Starved GFP-HPos–transfected cells (top) were loaded with OA for 15 min (bottom). Cells 
were fixed, neutral lipids were detected with Nile red (red), and the cells were analyzed by microscopy. Arrows indicate the HPos- and Nile red–positive 
structures. The insets show high-magnification details of pre-LDs (top and middle) and an emerging LD (bottom) labeled with Nile red. Bars: (top and bottom) 
20 µm; (middle) 2 µm; (insets) 0.5 µm. Error bars indicate the standard deviation of at least 60 structures from three independent experiments.
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(ACSL3) was recently described in nascent LDs (Poppelreuther 
et al., 2012). Finally, although the presence of diacylglycerol 
acyltransferase 2 (DGAT2) on LDs is controversial, the activity 
of DGAT2 is required to form triglycerides (Kuerschner et al., 
2008; Stone et al., 2009; Brasaemle and Wolins, 2012). Thus, 
these four proteins were tagged and cotransfected with HPos 
in starved cells. Emerging LDs were promoted with OA for 
7.5, 15, or 30 min, and colocalization between HPos and the 
markers was quantified in fixed cells.
Interestingly, DGAT2 did not colocalize with HPos in 
pre-LDs or emerging LDs (Fig. 5, A and B), which suggests 
that neutral lipid generation does not necessarily occur at the 
sites of storage. Plin2 and Plin3 demonstrated a low colocal-
ization with pre-LDs but progressively accumulated in emerg-
ing LDs. After 7.5 min, 50% of the emerging LDs contained 
Plin2 and Plin3. Recruitment of these proteins progressively 
increased with longer incubations. In agreement with previous 
studies (Wolins et al., 2005), Plin3 demonstrated a more rapid 
accumulation in emerging LDs than Plin2 (Fig. 5, A and B). 
A similar partial colocalization was observed between HPos 
and endogenous Plin2 and Plin3 (Fig. S1). Interestingly, the 
myc-tagged ACSL3 demonstrated an almost complete colo-
calization with HPos on pre-LDs and emerging LDs (Fig. 5, 
A and B; and Fig. S1), which suggests that ACSL3 is recruited 
earlier to LDs. Before and after OA, Plin3 additionally accumu-
lated in rounded structures that excluded ACSL3 but that were 
not LDs as determined by the absence of BODIPY 493/503, 
a neutral lipid dye (Fig. S1 E).
To examine whether the increased colocalization with 
HPos reflects the progressive incorporation of the markers into 
emerging LDs, we studied GFP-Plin2 incorporation via time-
lapse microscopy. Thus, OFP-HPos and GFP-Plin2 were co-
expressed in starved cells. After 5–7 min of OA addition, 
HPos-positive emerging LDs were formed. Immediately after 
formation these structures excluded Plin2 (Fig. 5 C). However, 
Plin2 was recruited to emerging LDs after a mean time of 4.5 ± 
1.8 min, which is consistent with the hypothesis that LD assem-
bly follows a coordinated sequence of protein recruitments 
(Wolins et al., 2005).
Endogenous ACSL3 is on pre-LDs and 
emerging LDs
Initially, ACSL3 was defined as an abundant LD protein in 
two proteomic screenings (Brasaemle et al., 2004; Fujimoto 
et al., 2004). Subsequently, biochemical analysis suggested that 
ACSL3 is the most abundant acyl-CoA synthetase long-chain 
family (ACSL) on LDs, and the role of this enzyme in LD for-
mation was suggested (Fujimoto et al., 2007). In agreement 
with this proposal, inhibition of the ACSLs activity with Triacsin C 
blocks the fatty acid–induced formation of LDs (Brasaemle 
et al., 2000; Fujimoto et al., 2007; Herms et al., 2013). Re-
cently, as commented above, a fragment of ACSL3 was shown 
in nascent LDs (Poppelreuther et al., 2012). Now, we have 
demonstrated that full-length ACSL3 is also early to arrive to 
emerging LD.
Further, antibodies against ACSL3 demonstrated that the 
endogenous enzyme (endACSL3) also accumulates in pre-LDs 
trafficking. Thus, the results confirm that HPos shifts from the 
ER into nascent LDs.
The assembly of lipoproteins occurs in defined nucle-
ation ER sites, but it has been proposed that LD assembly 
initiates spontaneously, simply by accumulation of neutral lip-
ids in the ER (Sturley and Hussain, 2012). If this model is cor-
rect, more lipid arrival should promote more spontaneous LD 
nucleation and more emerging LDs. To test this hypothesis, 
starved HPos-transfected cells were treated for 15 min with 
different OA concentrations, and the number and sizes of 
emerging LDs were quantified. Interestingly, consistent with 
the existence of a limiting step in LD assembly, lipid con-
centration determined the rate of growth of emerging LDs but 
not the number of emerging structures, which was relatively 
constant (Fig. 3 C).
Dynamics of lipid incorporation into  
pre-LDs and emerging LDs
We next determined whether lipids were incorporating into 
pre- and emerging LDs coincident with the HPos accumula-
tion. To visualize lipid dynamics, we used a BODIPY-tagged 
fatty acid (FA-BODIPY). This FA-BODIPY is a convenient 
tool because it can be followed in living cells and is esterified 
(Carten et al., 2011). In COS cells, esterification was observed 
early after lipid addition and was highly reduced with Triacsin C 
(acyl-CoA synthetases inhibitor, Fig. 4 E), which suggests 
lipid metabolism. Further, the signal corresponding to the 
esterified fatty acid was lost after saponification of the samples 
(not depicted).
Next, starved OFP-HPos–transfected cells were loaded 
with OA and the FA-BODIPY (t = 0) and visualized via time-
lapse microscopy (Videos 2 and 3). After just 10–30 s, the 
lipid accumulated within pre-LDs (Fig. 4 A, white circles). 
Emerging LDs appeared 5–7 min after OA addition (Fig. 4 A, 
red circles; and Video 3). In this image, two such emerging 
LDs are clearly visible at t = 10 min, and by t = 13 one of 
them has clearly started to accumulate FA-BODIPY (Fig. 4 A, 
blue arrow). By quantifying FA-BODIPY incorporation in 
multiple pre- and emerging LDs (Fig. 4 D), we observed that 
significant lipid packaging was evident within seconds in pre-
LDs (Fig. 4 B), but for emerging LDs there was a 2.3 ± 0.9 min 
mean delay between initial formation of LDs and FA-BODIPY 
accumulation (Fig. 4 C). After formation, the rate of lipid in-
corporation into emerging LDs was very similar to pre-LDs 
(Fig. 4 D). In conclusion, both pre-LDs and emerging LDs are 
bona fide sites of lipid accumulation but with different kinetics.
Dynamics of protein incorporation into  
pre-LDs and emerging LDs
HPos is recruited to nascent LDs before lipid accumulation be-
comes evident, and thus provides a convenient marker to char-
acterize initial stages of LD formation. We therefore used HPos 
as a temporal marker to examine the relative arrival of other 
proteins involved in the process such as Plin2, Plin3, ACSL3, 
and DGAT2. A current model suggests that nascent LDs are 
coated with Plin3, which is progressively replaced by Plin2 
(Wolins et al., 2005). A fragment of the acyl-CoA synthetase 3 
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ACSL3 regulates biogenesis, accumulation, 
copy number, and size of LDs
We quantified the number of pre- and emerging LDs in HPos-
transfected cells with reduced or increased levels of ACSL3 
(Fig. 7 A). The number of pre-LDs was significantly reduced 
in starved cells with lowered levels of ACSL3 (achieved by 
siRNA) and increased in cells cotransfected with the myc-
ACSL3 (Fig. 7 B). Further, the number of emerging LDs was 
significantly reduced when the siRNA-treated cells were in-
cubated with OA (Fig. 7 B, red bars) but increased in the cells 
cotransfected with the myc-ACSL3 (black bars). After 60 min, 
mature LDs, with a ring-like distribution of HPos, accumulated 
in more central regions of the cells. These larger LDs, which 
(Figs. 6 A and S1) and emerging LDs (Figs. 6 D and S1). In 
addition, colocalization between endACSL3 and HPos revealed 
the existence of additional pre-LDs in the central regions of 
starved cells that were not previously detected by accumula-
tion of HPos (Fig. 6 A, blue arrows). The complete redistri-
bution of ACSL3 from the ER into LDs was confirmed by 
fractionation of starved and OA-treated cells (Fig. 6 B) and by 
immunofluorescence microscopy (Fig. 6 C). The ACSL3 pro-
tein levels were slightly but consistently higher in starved cells 
than cells treated for 24 h with OA (Fig. 6 E). Altogether, these 
results established that endACSL3 is either recruited early 
into emerging LDs or, alternatively, that ACSL3 plays a role 
in LD assembly.
Figure 4. Dynamics of lipid incorporation into pre- and emerging LDs. (A) Starved OFP-HPos–transfected cells (top) were treated with OA and FA-BODIPY 
(bottom) and followed after 15 min by video microscopy (Video 2). Blue and green arrows indicate FA-BODIPY accumulation in pre-LDs. White circles 
indicate pre-LDs, and red circles emerging LDs. Arrows indicate a representative pre-LD. The degree of colocalization between HPos and FA-BODIPY at 
different times is indicated by the color of the arrow; red denotes a lack of colocalization, blue partial colocalization, and green complete colocalization. 
(B) A high-magnification sequence of lipid incorporation into the pre-LD indicated with a red arrow in the first panel of A (Video 3). The arrows mark the pre-
LD selected in A. (C) A high-magnification sequence of lipid incorporation into the emerging LD indicated with a blue arrow in the last panel of A (Video 3). 
Arrows mark a representative emerging LD. (D) Cells were treated as in A, and the FA-BODIPY intensity in at least 30 pre-LDs (black circles), emerging LDs 
(red circles), and the cytosol (gray circles) was quantified before and after OA in three independent experiments. Error bars indicate the standard deviation 
between experiments. ***, P < 0.001. (E) Thin-layer chromatography of fluorescent lipids in cells incubated 30, 60, or 120 min with OA and FA-BODIPY 
or 120 min but in the presence of 10 µM Triacsin C (TC). Bars: (A) 2 µm; (B and C) 0.5 µm.
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Figure 6. Endogenous ACSL3 colocalize with HPos in pre- and emerging LDs. (A) Starved GFP-HPos–transfected cells were fixed and labeled with an anti-
body for ACSL3. Green arrows indicate colocalization, white arrows indicate equivalent structures to pre-LDs found in nontransfected cells, and blue arrows 
indicate pre-LDs in central regions of the cell. (B) Distribution of ACSL3, Sec61, and Plin2 in starved cells (top) and cells additionally treated with OA for 24 h 
(bottom) and fractionated in sucrose density gradients. (C) Distribution of ACSL3 in cells treated with OA for 24 h. (D) Starved GFP-HPos–transfected cells 
were additionally treated with OA for 7.5 or 15 min, and cells were fixed and labeled with the ACSL3 antibody. Green arrows indicate colocalization. 
(E) ACSL3 protein levels detected by Western blotting of homogenates of normal cells (control), starved cells (24 h stv), and cells additionally treated with 
OA for 24 h (24 h OA). Bars: (A and C) 20 µm; (D) 1 µm.
Figure 5. Dynamics of protein incorporation into emerging LDs. (A and B) Starved cells (top) cotransfected with OFP-HPos and tagged forms of DGAT2, 
Plin2, Plin3, and ACSL3 (green), were additionally treated with OA for 7.5, 15 (bottom), or 30 min and analyzed by microscopy. Arrows indicate the 
structures selected for the high-magnification panels. Bars: (main panels) 2 µm; (insets) 0.5 µm. (B) The percentage of HPos-positive pre- and emerging 
LDs that accumulated the cotransfected proteins. Error bars indicate the standard deviation of three independent experiments. (C) Starved OFP-HPos and 
GFP-Plin2 cotransfected cells were loaded with OA and followed for 15 min by video microscopy. After formation (t = 0), HPos-positive emerging LDs 
require a mean time of 4.5 ± 1.8 min to be recognized by Plin2 (blue and green arrows). Arrows mark a representative emerging LD, and the color of the 
arrow indicates the degree of colocalization between HPos and Plin2. Bar, 1 µm.
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absence of ACSL3 (Fig. 7 C) but accelerated by overexpression 
of myc-ACSL3 (Fig. 7 D). Decreased LD biogenesis in the 
absence of ACSL3 was also observed when LDs were pro-
moted with palmitic acid (Fig. 7 E). Further, lack of ACSL3 
completely inhibited the incorporation of a radiolabeled OA 
into triacylglycerols, as measured by thin layer chromatography 
(unpublished data).
Changes in LD assembly should also determine long-term 
neutral lipid accumulation. Thus, cells transfected with the 
ACSL3 siRNA or with an unrelated siRNA were treated for 12 h 
with increasing OA concentrations. LDs were labeled with Nile 
were not considered in this initial analysis of emerging LDs, 
coexisted with peripheral and small HPos structures, suggest-
ing that new rounds of emerging LDs occur after 30 min of the 
lipid arrival (an example is shown in Fig. 1 F).
To demonstrate that the number of pre- and emerging 
LDs correlates with the early storage of neutral lipids occur-
ring in these structures (Fig. 3 D), starved cells transfected with 
the siRNA for ACSL3 or the myc-ACSL3 were loaded with 
OA and labeled with neutral lipid dyes, then cellular fluores-
cence was measured via flow cytometry (Herms et al., 2013). 
Accumulation of neutral lipids was completely inhibited in the 
Figure 7. ACSL3 regulates LD biogenesis and neutral lipid accumulation. (A) After transfection with the ACSL3 siRNA or an unrelated siRNA, the protein 
levels of ACSL3 were determined by Western blotting. (B) The number of HPos-positive structures in starved cells (pre-LDs) or in cells additionally incubated 
with OA (emerging LDs) was quantified. Red and white bars correspond to cells treated for 24 h with the ACSL3 siRNA (red bars) or the unrelated siRNA 
(white bars), transfected with HPos, and additionally starved for 24 h. In some of these experiments Triacsin C (slashed bars) was present during starva-
tion and loading. Gray and black bars correspond to cells transfected with HPos (gray bars) or cotransfected with HPos and myc-ACSL3 (black bars) 
and starved for an additional 24 h. (C–E) Neutral lipids were quantified by flow cytometry after starvation or the indicated times of fatty acid addition in 
cells previously transfected with the ACSL3 siRNA (red bars) or the unrelated siRNA (white bars), nontransfected cells (gray bars), or cells transfected with 
myc-ACSL3 (black bars). In some experiments cells were additionally incubated with Triacsin C (slashed bars). (F–H) Cells treated as in C were loaded 
with OA for 12 h and stained with Nile red (red in F) and Hoechst to visualize the nucleus (blue). In these images the size (G) and number (H) of LDs were 
quantified. Bar, 20 µm. Error bars indicate the standard deviation of three independent experiments. *, P < 0.05; **, P < 0.01.
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proteins such as GFP-Dga1 (t1/2 = 82.9 s) proposed to laterally 
move between the ER and LDs (Jacquier et al., 2011).
Pre-LDs could be mature LDs assembled before the 
starvation and incompletely metabolized in a lipid-depleted 
environment. However, pre-LDs were only partially recognized 
by Plin2 and Plin3 (Figs. 5 and S1), which suggests that this is 
not the case. Further, pre-LDs were not formed during the starva-
tion period, as the number of these domains was not reduced 
by Triacsin C (Fig. 7 B). Thus, one possibility is that pre-LDs 
are actually LDs that were forming before the time that cells 
were submitted to lipid deprivation, and thus equivalent struc-
tures to the emerging LDs that are only partially recognized by 
Plin proteins (Fig. 5, A and B; and Fig. S1). However, such a 
model would require that in the absence of a lipid supply, emerging 
LDs should be stable in the ER.
We therefore treated starved cells for 10 min with OA in 
order to promote emerging LDs, and then cells were resub-
mitted to starvation for 16 h to test whether these LDs were 
stable in the absence of extracellular lipids. Flow cytometry 
analysis demonstrated that the accumulation of lipids pro-
moted by the lipid pulse was stable during the second starvation 
period (Fig. 8 E). In contrast, mature LDs formed with OA for 
24 h and submitted to an identical starvation were metabolized 
(Fig. 8 F). The microscopy analysis of cells stained with Nile 
red revealed that, in contrast to starved cells (Fig. 8 G), cells 
submitted to the single pulse of lipids accumulated numerous 
LDs (Fig. 8 H) and that the lipid accumulation persisted after 
the second starvation (Fig. 8 I). The stability of these early 
formed LDs was confirmed in other cell lines such as 3T3-L1 
and mouse embryonic fibroblasts (unpublished data). These 
structures excluded endogenous Plin3 (not depicted) and accu-
mulated endogenous ACSL3 (Fig. 8 J).
We then characterized the morphology of pre-LDs by 
electron microscopy. Cells were treated as indicated above and 
processed with no primary fixative and a very quick nonper-
turbing freeze substitution protocol. We found that after the 
second starvation, cells accumulated numerous electron lucent 
structures that were not present in starved cells (Fig. 9, A and B). 
These pre-LDs were often close to the ER, clearly surrounded 
by a monolayer, and demonstrated a very consistent size (257.6 ± 
31 nm), as expected from a synchronized process of biogenesis 
(Fig. 3). In some cases a likely interaction between the LDs 
and the ER (Fig. 9 C, arrows) and with other LDs (Fig. 9 D, 
arrows) was observed.
To get further structural details, we used electron tomog-
raphy (Videos 4 and 5). Cells were treated and processed as 
above and the specimen (300 nm thick) was tilted ±60° in both 
axes, taking images every 1 or 2° (Nixon et al., 2009). With 
this 3D view we did not observe any completely spherical LDs 
(Fig. 9 E), which suggests that pre-LDs may be relatively flat 
structures (Figs. 9 A and 10). Tomography clearly illustrated 
that pre-LDs are surrounded by a monolayer, which was espe-
cially obvious when compared with the ER bilayer distin-
guished by the presence of electron-dense ribosomes (Fig. 9 F 
and Video 4). Interestingly, because tomography allows visu-
alization of the organelle at different levels, we observed that 
almost all the pre-LDs showed at least one contact with the ER, 
red, and final LD copy number and size were quantified in 
microscopy images (Fig. 7 F). In control cells, LD size was rela-
tively constant over a broad range of OA concentrations (Fig. 7 G, 
white bars), while the number of LDs increased as a function 
of lipid concentration (Fig. 7 H, white bars). The lack of ACSL3 
drastically reduced both the size and the number of LDs (Fig. 7, 
G and H, red bars). The flow cytometry analysis also demonstrated 
that cells with lowered levels of ACSL3 accumulated fewer 
LDs when treated for 24 h with OA or palmitic acid (Fig. 7 E). 
Further, the inhibition of LD formation after the ACSL3 
siRNA was rescued by an ectopically expressed siRNA-resistant 
ACSL3 (Fig. S3, D and E). In addition, ACSL3 also determined 
the LD content of hepatic cells (Fig. S4).
To analyze whether the enzymatic activity of ACSL3 
determines LD formation, cells were loaded with OA, but in 
the presence of Triacsin C, an inhibitor of ACSL1, ACSL3, and 
ACSL4 (Soupene and Kuypers, 2008). LD nucleation and ac-
cumulation were almost completely inhibited by Triacsin C 
(Fig. 7, B and E, slashed bars). A quantitative RT-PCR (qRT-
PCR) analysis demonstrated that ACSL1 and ACSL4 are also 
expressed in COS cells. When normalized to the ACSL3 ex-
pression, ACSL4 was the most abundant member (×1.2), and 
ACSL1 demonstrated a lower but consistent expression (×0.2). 
However, siRNAs for these ACSLs did not affect LD accu-
mulation (Fig. S2, A–E). Further, when GFP-tagged forms 
of these ACSLs were expressed to identical levels, only the 
GFP-ACSL3 increased LD formation and accumulation (Fig. S2, 
F–H), which suggests that ACSL3 is the member involved in 
LD biogenesis. Interestingly, a transfected GFP-ACSL3 with-
out the Gate domain (ACSL3gate), and thus with no enzy-
matic activity (Fig. S3), also accelerated the early storage of 
neutral lipids and partially increased LD accumulation (Fig. S3, 
F and G). This lends support to the hypothesis that although 
the enzymatic activity of ACSL3 is required for LD nucleation 
and expansion, other properties of the enzyme also cooperate 
during the process.
Pre-LDs are stable LDs in restricted  
ER microdomains
Finally, we wanted to characterize the pre-LDs, and hypothe-
sized that these structures are LDs stably assembled in ER 
membranes and specialized in the rapid packaging of arriving 
lipids. As expected, pre-LDs accumulated different HPos pep-
tides (OFP-HPos and GFP-Hyd-ER3; Ingelmo-Torres et al., 
2009) but completely excluded HNeu (Fig. 8, B and A). How-
ever, pre-LDs were only partially recognized by ectopically 
expressed or endogenous Plin proteins (Fig. 8 C and Fig. S1). 
First, to address if pre-LDs are different from the rest of the 
ER, we investigated the mobility of HPos and analyzed protein 
dynamics by FRAP. Most ER-localized proteins are highly 
mobile (Lippincott-Schwartz et al., 2001), and indeed when 
GFP-HPos in tubules was photobleached demonstrated a mo-
bile fraction of 99% in 20 s (Fig. 8 D, white circles). In striking 
contrast, when the protein on pre-LDs was photobleached, the 
mobile fraction was 16% in 20 s (t1/2 = 62.8 s; Fig. 8 D, red 
circles). Likely reflecting the smaller size of the peptide, these 
kinetics are slightly more rapid but consistent with other LD 
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Discussion
The ER is a continuous and dynamic system of connected mem-
branes organized in different subdomains, including the nuclear 
envelope, central rough sheet-like structures, and a polygonal 
network of tubules extending into the cell periphery (Park 
and Blackstone, 2010). The rough ER participates simulta-
neously in protein synthesis, quality control, and protein and 
and in some cases a likely continuity between the membranes 
of both organelles was observed (Fig. 9 F, arrows). In addition, 
pre-LDs were apparently connected to neighboring LDs by a 
continuous monolayer (Fig. 9 G, arrows; and Video 4), perhaps 
suggesting that those nearby pre-LDs were formed in the same 
ER tubule. Some pre-LDs demonstrated a simultaneous triple 
connection, for example, with two ER tubules and one LD 
(Fig. 9 H, arrows).
Figure 8. Pre-LDs are restricted and stable ER microdomains. (A and B) Starved cells cotransfected with OFP-HPos and GFP-HNeu (A) or OFP-HPos and 
GFP-HydER3 (an HPos peptide with the positive sequence of ALDI; B) were fixed and analyzed by confocal microscopy. Bars: (left) 25 µm; (right) 2 µm; 
(insets) 0.5 µm. (C) Starved GFP-HPos–transfected cells were fixed, and distribution of endogenous Plin3 was analyzed with a specific antibody (red). Red 
arrows indicate the pre-LDs selected for the high-magnification panel. Bars: (main panels) 2 µm; (insets) 0.5 µm. (D) Starved GFP-HPos–transfected cells 
were photobleached in tubules (black circles) or in pre-LDs (red circles). Fluorescence recovery was quantified. (E and F) Starved cells (stv) were treated for 
10 min (E) or 24 h (F) with OA and then submitted to a second starvation for an additional 16 h (16 h stv). Neutral lipids were labeled with Nile red and 
quantified by flow cytometry. (G–I) Cells treated as in E were stained with Nile red and analyzed by microscopy. Bars: (top) 25 µm; (bottom) 2 µm. (J) Cells 
submitted to the second starvation period as in E (16 h stv) were fixed and labeled with Nile red (red) and ACSL3 antibody (green). Bars (main panel) 25 µm; 
(insets) 0.5 µm. Error bars indicate the standard deviation of five (D) or three (E and F) independent experiments.
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free fatty acids and cholesterol can be toxic, they are rapidly 
esterified into neutral lipids that accumulate in LDs. In mam-
malian cells, the ER harbors enzymes required for neutral lipid 
synthesis (Buhman et al., 2001), which suggests that this 
organelle is also specialized in lipid storage. However, this ER-
generation model has been continuously challenged because sites 
and mechanisms of LD nucleation remain poorly understood.
Here, with fluorescent peptides that shift between the ER 
and forming LDs, we observed three early aspects of lipid 
lipid secretion. The tubules specialize in detoxification, lipid 
synthesis, and interaction with other organelles. Remarkably, 
although all these ER subdomains and microdomains are con-
tiguous and physically in contact, highly selective yet poorly 
understood mechanisms must exist to ensure that they are func-
tionally segregated.
Fatty acids and cholesterol are key molecules in many 
cellular processes ranging from the production of metabolic en-
ergy to the regulation of membranes fluidity. However, because 
Figure 9. Ultrastructure of pre-LDs. Cells 
submitted to the second starvation period as 
in Fig. 8 E (16 h stv) were analyzed by elec-
tron microscopy (A–D) and electron tomogra-
phy (E–H). A, B, and E show a general view 
of the cells. Arrows in C, F, and H indicate 
possible interactions between the ER and pre-
LDs. Arrows in D, G, and H indicate possible 
interactions between neighboring pre-LDs. For 
additional details, E and G correspond to the 
central pre-LD of Video 4, and F corresponds 
to the central pre-LD in Video 5.
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storage (Welte, 2007), protein degradation (Wang and Lee, 2012), 
or immunity (Anand et al., 2012), the stability of the pre-LDs 
might facilitate these roles even during a prolonged absence of 
extracellular lipids.
How and where are these pre-LDs and LDs formed? Most 
models suggest that LDs originate in the ER bilayer and then 
remain connected to the ER, or alternatively bud off to become 
independent organelles (Walther and Farese, 2012). Based on 
freeze-fracture electron microscopy, it has been proposed that 
the LDs grow within a concave depression of the ER or “egg-
cup” (Robenek et al., 2006). Other models hypothesize vesic-
ular budding (Walther and Farese, 2009) or bicelle excision 
from the ER (Ploegh, 2007).
Here, our simultaneous visualization of emerging LDs 
(HPos) and the neighboring ER tubules (HNeu), in conjunction 
with the electron tomography, supports the overall hypothesis 
that LDs do indeed originate in the ER. HPos rapidly moves 
from the ER into pre- and nascent LDs and, at least during the 
initial steps of biogenesis, all our images demonstrate that LDs 
are in contact with the ER (Figs. 2, 5, 8, and S1). Electron mi-
croscopy and tomography confirm that LDs are clearly sur-
rounded by a single monolayer, which is consistent with the 
idea that neutral lipid deposition occurs between the two leaflets 
of the ER bilayer. Rather than an “eggcup,” the tomography 
demonstrates multiple but discrete interactions between the 
ER and LDs and in some cases a likely continuity between 
both membranes. Real-time microscopy of emerging LD forma-
tion did not show perceptible budding or detachment processes 
storage. First, arriving lipids are packed in preexisting, or re-
sistant to starvation, LDs. Second, the continuous lipid ar-
rival promotes the formation of a first round of emerging LDs. 
This assembly is a synchronized stepwise process of protein 
gathering, lipid accumulation, and recognition by Plin2 and 
Plin3. The concentration of arriving lipids determines the rate 
of growth of emerging LDs but not the copy number of emerg-
ing structures, which suggests that the nucleation domains are 
predefined in the ER. Third, after this initial nucleation, and 
proportionally to lipid availability, more LDs will be progres-
sively nucleated. Restricted by a relatively constant maximal 
size of individual LDs, cells nucleate additional LDs to store 
additional lipids (Fig. 7, G and H).
We hypothesize that these successive events reflect dif-
ferent stages of the same stepwise maturation process (Fig. 10). 
This scenario is possible because emerging LDs are stable in 
the absence of an additional lipid supply. Lipid arrival will 
promote gradual progression of each step into the next, but lipid 
depletion will stop progression, though not reverse it, until new 
lipid arrives. A possible explanation for such stability is that 
these early LDs may not have acquired the protein composition 
that facilitates lipolysis, and thus, maturation of LDs may be 
necessary to allow access of lipases. The existence of a set of 
LDs resistant to starvation guarantees efficient packaging in 
the ER of occasional lipids, and if lipid arrival persists, the 
assembly of new LDs will allow medium- and long-term stor-
age. Further, because LDs are not simply sites of lipid storage 
but are also involved in other cellular functions, such as protein 
Figure 10. Model of a self-reinforcing stepwise LD formation. Continuous lipid arrival promotes the formation of emerging LDs in 5 min. Initially, newly 
synthesized neutral lipids can be integrated in the ER membrane. However, addition of new triglycerides to the globule will promote phase separation 
and the deposition of the globule between the two leaflets of the ER bilayer. These globules produce a transient curvature of the ER membrane or move 
two-dimensionally within the bilayer, fuse with other globules, and generate curvature of the ER. Proteins with amphipathic  helices, such as HPos or 
ACSL3, are then attracted to these regions. The stable interaction of these proteins nucleates unstable globules and marks the onset of LD biogenesis. The 
enrichment of ACSL3 locally generates the acyl-CoA required for LD growth and expansion but also numerous bioactive lipid intermediates. Emerging 
LDs expand and the lipid intermediates are recognized by Plin proteins. If lipid supply ends, these structures become stable and remain connected to the 
peripheral ER. If lipid supply persists, emerging LDs increase in size to become early and mature LDs. Early and mature LDs accumulate in the central ER 
and are metabolized during starvation.
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demonstrated that ACSL3 channels fatty acids into nascent LDs. 
The absence of ACSL3 significantly reduces nucleation of 
emerging LDs, short- and long-term accumulation of neutral 
lipids, and the size and number of mature LDs. On the contrary, 
down-regulation or overexpression of other family members 
did not modify the process. Reduced ACSL3 levels in the nucle-
ation sites likely decrease local accumulation of acyl-CoA, 
decrease substrate availability for the reactions described above, 
and thus reduce the efficiency of the process that relies on lipids 
activated elsewhere. Interestingly, similarly to perilipins, the 
expression of the ACSL family members is regulated during 
differentiation of 3T3 fibroblasts into adipocytes. ACSL1 is 
up-regulated (similar to Plin1) but ACSL3 is highly down-
regulated (similar to Plin2 and Plin3; Sandoval et al., 2008). 
Thus, in mature 3T3 adipocytes it is likely that factors other 
than ACSL3 assist LD nucleation and expansion.
Although the enzymatic activity of ACSL3 is crucial for 
LD formation, clearly suggested by the complete inhibition 
caused by Triacsin C, other functions might also be important, 
as ACSL3 lacking enzymatic activity also increased LD nucle-
ation. Although this initial observation requires further analysis, 
and ACSL3’s amphipathic helices might simply contribute to 
membrane curvature as suggested above, the capacity of ACSL3 
for interaction with other LD proteins could potentially orga-
nize specific regions within the complex mixture of proteins 
and lipids residing in or in transit on the ER tubules. Indeed, 
ACSL3 interacts with Spartin/SPG20 and AUP1 that are in turn 
crucial scaffolding proteins that determine LD composition, 
size, and numbers (Milewska et al., 2009; Klemm et al., 2011). 
Accordingly, ACSL3 has been found in complexes with neutral 
lipid synthesis enzymes (Wilfling et al., 2013). In addition, 
dynamic relocation of the enzyme between the ER tubules, pre-
LDs, and LDs might represent a cellular homeostatic sensor 
given that ACSL3 regulates the activity of key lipogenic tran-
scription factors such as PPAR-, ChREBP, SREBP1-c, and 
LXR- (Bu et al., 2009).
In conclusion, the model proteins generated for this 
study enabled us to anticipate, visualize, and characterize LDs 
emerging from the ER membranes. We demonstrate that early 
LDs are stable ER microdomains in the absence of lipid supply, 
and that lipid storage occurs via multiple processes with dif-
ferent kinetics. Finally, we have shown that ACSL3 is important 
for efficient LD nucleation and that ACSL3 is the family mem-
ber that efficiently channels lipids into nascent LDs.
Materials and methods
Antibodies and reagents
OA and mowiol were obtained from EMD Millipore. Fatty acid–free BSA 
(A8806), palmitic acid, sucrose, saponin, brefeldin A, platensimycin, cy-
cloheximide, and Nile red were obtained from Sigma-Aldrich. BODIPY 
493/503, Hoechst-33258, and BODIPY-FL C16 were from Molecular 
Probes. LipidTOX Deep Red Neutral Lipid Stain was from Life Technologies, 
Invitrogen. Paraformaldehyde was from Electron Microscopy Sciences and 
Triacsin C from Santa Cruz Biotechnology, Inc.
Rabbit polyclonal antibody anti-GFP (ab290), rabbit polyclonal 
anti-Plin2 (ab52355), rabbit polyclonal anti-ACSL1 (ab76702), rabbit 
monoclonal anti-ACSL4/FACL4 (ab155282), mouse monoclonal anti-actin 
(ab40864), and mouse monoclonal anti–c-myc (ab32) were from Abcam. 
Rabbit polyclonal anti-Sec61  (07–204) was from EMD Millipore. The 
involving ER membranes (Fig. 3). Further, bicelle formation or 
vesicular budding are inconsistent with the observation that 
LDs often have extended connections with neighboring LDs.
Thus, we favor a “blister-like” organization of lipid glob-
ules in the bilayer, observed in early electron microscopy stud-
ies of the ER of plants and proposed using simulation models 
(Wanner et al., 1981; Khandelia et al., 2010). Initially, newly 
synthesized neutral lipids can be integrated in the ER mem-
brane (for review see Suzuki et al., 2011). However, continuous 
lipid arrival increases the relative concentration of triacyl-
glycerols in the membrane, promoting phase separation, and the 
deposition of globules of neutral lipids between the two leaf-
lets of the ER bilayer. Biophysical models predict that the di-
ameters of these primordial globules are 20 nm (Zanghellini 
et al., 2010). These globules can already cause transient curva-
ture of the ER membrane, or move two-dimensionally within 
the bilayer, fusing with other globules, and generate a more 
pronounced curvature (Khandelia et al., 2010; Suzuki et al., 2011; 
Fig. 10). Proteins with amphipathic  helices anchored to the 
cytosolic side of the ER can rapidly recognize curved mem-
branes, acting as neutral lipid sensors (McMahon and Gallop, 
2005). Consistent with this hypothesis, a significant number of 
proteins are anchored to LDs by amphipathic helices (for re-
view see Walther and Farese, 2012). The strong and stable inter-
action of these proteins with the membrane likely provides the 
equilibrium required to nucleate unstable globules in defined 
ER sites, mark the onset of LD biogenesis, and produce the blister-
like morphology of the ER bilayer.
The above mechanism could accumulate ACSL3 at 
these ER sites, as this enzyme contains amphipathic helices 
(Poppelreuther et al., 2012). Our preliminary in silico analysis 
confirms this possibility for ACSL3 and HPos (Fig. S5). In any 
case, enrichment of ACSL3 on emerging LDs will generate a 
concomitant local enrichment of acyl-CoA, which is essential 
to synthesize lysophosphatidic acid, diacylglycerol, triacylglyc-
erol, and phospholipids required to increase the size of the 
primordial globule and the expansion of the emerging LD 
(Kuerschner et al., 2008; Skinner et al., 2009; Adeyo et al., 
2011; Fei et al., 2011; Krahmer et al., 2011; Moessinger et al., 
2011; Wilfling et al., 2013). In parallel, transient generation of 
active lipid intermediates, such as phosphatidic acid and diacyl-
glycerol, will also modify the shape of the membrane and re-
cruit proteins (for review see Brasaemle and Wolins, 2012). 
Such a self-reinforcing process is consistent with the kinetics of 
delayed formation of emerging LDs after lipid arrival and with 
the observation that pre-LDs, containing ACSL3, are able to 
initially pack arriving lipids more rapidly.
The ACSL family mediates the conversion of long-chain 
fatty acids into acyl-CoA, and it is assumed that each ACSL 
isoform channels with high specificity the fatty acid to distinct 
metabolic fates (Ellis et al., 2010). Although the presence of 
ACSL1 and ACSL4 on LDs was suggested by proteomic analysis 
(Brasaemle et al., 2004; Liu et al., 2004; Wilfling et al., 2013), 
this finding was questioned (Poppelreuther et al., 2012). In con-
trast, it seems accepted that the ACSL3 is on LDs, and accord-
ingly a role of this enzyme during LD biogenesis was proposed. 
Here, we have experimentally addressed this possibility and 
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Confocal microscopy
Cells were fixed in 4% PFA diluted in PBS for 1 h at room temperature. 
In some experiments, fixed cells were stained with Nile red added to 
Mowiol at 1:1,000 dilution (from saturated stock solution in acetone) 
or BODIPY 493/503 for 30 min in PBS. For immunofluorescence micros-
copy, fixed cells were permeabilized in 0.1% saponin in PBS for 10 min 
at RT, and blocked with 0.2% BSA in PBS for 10 min at room tempera-
ture. Then cells were incubated with anti-ACSL3 (1:200), anti-Plin2/
ADRP (1:100), anti-Plin3/TIP47 (1:200) or anti-myc (1:250) for 1 h at 
room temperature, followed by three washes in PBS and incubation 
with Alexa Fluor 555– or 647–conjugated anti–mouse or anti–rabbit 
IgG antibody (1:250) for 45 min, washed in PBS, and mounted in 
Mowiol (Sigma-Aldrich).
Cells were examined using a 63× oil immersion objective in a 
laser scanning confocal microscope (TCS SL; Leica) with a pinhole of 
1.5 AU. All images are single confocal sections. For quantification, trans-
fected cells were randomly selected, and image analysis was performed 
with Photoshop CS software (Adobe). The quantifications of size and 
number of pre-LDs and emerging LDs, and the colocalization of trans-
fected proteins with HPos, were performed in three independent experi-
ments and at least 20 cells per experiment using ImageJ software (National 
Institutes of Health).
The number and size of mature LDs (Fig. 7, G and H) was calculated 
using the custom-written MATLAB code. In these experiments, living cells 
were labeled by addition of 0.3 µM Hoechst-33258 and 0.83 µg/ml Nile 
red in the culture media. Cells were randomly selected, and images were 
captured in a laser scanning confocal spectral microscope (TCS SP5; 
Leica) equipped with an incubation control system (37°C and 5% CO2) 
with a 63× oil immersion objective lens with an NA of 1.4, using a 405-nm 
and 561-nm laser lines, respectively. Mean area of a single LD was calcu-
lated by scoring all the structures that were <800 nm in diameter, which is 
the diameter of the largest single LD observed. Images were acquired with 
a pixel size of 80 nm to accurately resolve these structures, according to 
Nyquist theorem. The sum total of the areas of all LDs whose diameter was 
<800 nm was divided by the number of LDs <800 nm in diameter. Cells 
treated with high OA had clusters with inseparable LDs. To estimate the 
number of LDs/cell in such cells, the total area of LDs including the clusters 
was divided by the mean area of single LD in each cell.
Time-lapse video microscopy
Time-lapse video microscopy was performed with a laser scanning confo-
cal spectral microscope (TCS SP5; Leica) equipped with an incubation 
control system (37°C, 5% CO2). Cells were transfected and treated as ex-
plained above. In some experiments, cells were additionally treated with 
10 µg/ml of cycloheximide for 3 h to reduce the pool of newly synthe-
sized protein. Cells were selected for the labeling of well-defined ER 
elements. OA (175 µg/ml) and in some cases BODIPY-FLC16 (FA-BODIPY, 
1 µM) were added and images were captured every 9 s with a 63× oil 
immersion objective lens with an NA of 1.4, at 6× zoom, using 488-nm 
and 561-nm laser lines. Movies were digitally treated with the Leica Ap-
plication Suite software (3.10 build 8587). In the experiments using 
FA-BODIPY, the mean background fluorescence was calculated from at 
least three different cytosolic regions at time 0 (just before the addition of 
the green fatty acid). This background was identically subtracted from all 
the frames of the movies. In the case of the transfected peptides, the mean 
unspecific background was calculated from an extracellular region at 
time 0 and identically subtracted from all the frames of the movies. Finally, 
all the frames of the movies were identically filtered with a Gaussian blur 
filter using radius 2. Fluorescence intensity and LDs size were quantified 
using Photoshop CS software (Adobe) from three independent experi-
ments and at least 20 structures per experiment.
FRAP
FRAP experiments were performed on a laser scanning confocal spectral 
microscope (TCS SP5; Leica) equipped with an incubation control system 
(37°C, 5% CO2). A defined region of interest (ROI, 0.5 µm of diameter) 
was photobleached at full laser power (100% power, 50–80 iterations), 
and recovery of fluorescence was monitored by scanning the ROI at low 
laser power (1–4% of laser power, 20 s of 0.75-s interval scans). Fluores-
cence intensity was normalized to the prebleach intensity. Any loss of fluo-
rescence during the recording was corrected with unbleached regions of 
the cell. The values were fitted to a nonlinear regression equation, F(t) = 
M[1  exp(t/t1/2)], where F is the fluorescence intensity, M is the mobile 
fraction, and t1/2 is the time constant.
mouse polyclonal anti-ACSL3 (B01P) was from Abnova. Guinea pig poly-
clonal antibody against Plin3 was from Progen. Alexa Fluor 555– and 647–
conjugated secondary antibodies were from Life Technologies, Invitrogen.
Silencer siRNAs against human ACSL1, ACSL3, and ACSL4 were 
obtained from QIAGEN in a FlexiTube format. The siRNA target sequences 
were as follows: For ACSL1, 5-AAGGATGCTTTGCTTATTCGA-3, 5-TCG-
CAGCGGCATCATCAGAAA-3, 5-CAGGTGTTTGTCCACGGAGAA-3; 
for ACSL3, 5-CCGAAGTGTGGGACTACAATA-3, 5-AACCACGCAGC-
GATTCATGAA-3, 5-ACCGCGTGAGTTAAGATTTAA-3, and 5-TAGCTC-
GAAAGAAAGGACTTA-3; for ACSL4, 5-ATGCATCATAGCAATTTGATA-3, 
5-TTGGAGCGATTTGAAATTCCA-3, 5-CAGATTATAGATCGTAAGAAA-3, 
and 5-AAGGGCAGAGTTACTTGATAA-3. The nonrelated siRNA used 
was against GFP from Thermo Fisher Scientific.
Plasmids
Mutant proteins were N-terminally tagged with the GFP (unless otherwise 
indicated). Standard YUX cloning, using primers containing BspEI (for-
ward) and SmaI (backward) restriction sites, was used to synthesize 
GFP-HPos and GFP-HNeu. The orange-tagged HPos mutant was obtained 
after subcloning of the GFP-HPos into mOrange expression vector provided 
by R.Y. Tsien (Howard Hughes Medical Institute, Chevy Chase, MD). The 
mOrange expression vector was obtained by amplification of the fluores-
cent protein with a 5 primer encoding an AgeI site and a 3 primer encod-
ing a BspEI site and ligated into similarly digested pEGFP-C1 (Takara Bio 
Inc.) cloning vector backbones. The pEGFP-DGAT2 construct was derived 
from the plasmid pCDNA3-Flag-DGAT2 provided by R.V. Farese (Gladstone 
Institute of Cardiovascular Disease, San Francisco, CA) and subcloned 
into a pEGFP-C3 expression vector to generate a GFP fusion. The 
pCDNA4/TO-myc-ACSL3 was provided by N. Yamaguchi (Graduate 
School of Pharmaceutical Sciences, Chiba, Japan). The construct was gen-
erated by subcloning human myc-ACSL3 cDNA into pCDNA4/TO vector 
(Invitrogen). pCDNA 3×myc-tagged Plin3 was provided by S. Pfeffer 
(Stanford University School of Medicine, Stanford, CA). The construct was 
obtained by amplification of the full length by PCR with the introduction of 
EcoRI and XbaI sites for cloning into pcDNA3.1 and a 5 EcoRV site for the 
insertion of the 3× Myc repeats generated by PCR. The pEFGP vector en-
coding human Plin2 was provided by J. McLauchlan (Institute of Virology, 
Glasgow, Scotland).
For the expression vector encoding siRNA-resistant ACSL3, five si-
lent mutations were introduced in each of the four siRNA target sequences. 
The construct ACSL3 Gate results from deletion of the amino acids 
314–339 (fatty acid Gate domain; Soupene et al., 2010) from siRNA-
resistant ACSL3. Both cDNAs were purchased from GenScript and sub-
cloned in pEGFP vector. GFP-tagged expression vectors containing human 
cDNAs for ACSL1, ACSL4, and ACSL5 (catalog Nos. RG208196, 
RG205356, RG201076, respectively) were purchased from OriGene.
Cell culture
COS-1 cells (African green monkey kidney fibroblast-like cell line) were 
cultured in 5% vol/vol FCS and Huh7 and HepG2 (human hepatoma cell 
lines) in 10% vol/vol FCS (Biological Industries). All cells were main-
tained at 37°C and 5% CO2 in DMEM (Biological Industries) supplemented 
with 4 mM l-glutamine (Sigma-Aldrich), 1 mM pyruvate (Sigma-Aldrich), 
nonessential amino acids (Biological Industries), 50 U/ml penicillin, and 
50 µg/ml streptomycin sulfate (Biological Industries). Starvation was per-
formed by culturing cells in DMEM, l-glutamine, pyruvate, and nonessen-
tial amino acids but in the absence of serum for 24 h. To promote the 
formation of LDs, cells were treated with OA and/or palmitic acid conju-
gated to fatty acid–free BSA at a molar ratio of 6:1 and added to the cul-
ture medium to give a final concentration of 175 µg/ml (unless other 
concentration is specified).
Transfections
The siRNA transfections were performed using Lipofectamine RNAiMAX 
reagent (Invitrogen, Life Technologies). All procedures were performed ac-
cording to the manufacturer’s instructions. For DNA transfection experi-
ments, cells plated at 18,000 cells/cm2 on glass coverslips the day before 
were transfected with the corresponding fusion proteins using Effectene 
Transfection Reagent (QIAGEN). To reduce the number of LDs, transfection 
was performed in DMEM supplemented with 0.5% FCS and changed to 
DMEM without serum 6 h after transfection. The precise concentration of 
each construct was specifically adjusted to get a similar expression and 
transfection efficiency. In experiments involving siRNA and DNA transfec-
tions, the DNA was transfected 24 h later than the siRNA.
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Western blotting
Gel electrophoresis and Western blotting were performed as described 
previously (Turró et al., 2006). Membranes were incubated with anti-GFP 
(1:1,000), anti-ACSL1 (1:500), anti-ACSL3 (1:1,000), anti-ACSL4/FACL4 
(1:10,000), anti-actin (1:10,000), anti-sec61 (1:1,000), or anti-Plin2 
(1:500). After the incubation with primary antibody (see antibodies section 
for details of the antibodies), the membrane was washed and incubated 
with peroxidase-conjugated secondary antibodies (1:3,000 dilution; Bio-
Rad Laboratories), and detected using ECL detection (Biological Industries, 
Ltd.) on medical x-ray film (Fujifilm).
Acyl-CoA synthase activity
Total acyl-CoA synthetase activity was measured as described previously 
(Asp et al., 2009). In brief, cells were harvested in 200 µl of ACSL buffer 
(50 mM KH2PO4, 10% glycerol, and 1 mM EDTA, pH 7.4) at 4°C and 
lysed by sonication. Protein was quantified and 100 µg of protein was 
incubated during 20 min at 37°C in a reaction mix containing 175 mM 
Tris-HCL, 8 mM MgCl2, 5 mM dithiothreitol, 10 mM ATP, 250 µM coen-
zyme A sodium salt (C3144; Sigma-Aldrich), and 50 µM (0.2 µCi) of 
BSA-conjugated OA trace-labeled with [1-14C]OA (NEC-317; PerkinElmer) 
at 1:6 mol/mol. After that, 1 ml of Doles reagent (2-propanol/hexane/
H2SO4 at 8:2:0.2), 2 ml of heptane, and 0.5 ml of water were added to 
each tube, and, after a vortex, the organic phase was discarded. Then, the 
aqueous phase was washed three times, adding 2 ml of heptane, and, 
after a vortex, the organic phase was discarded. Finally, the radioactivity 
of the aqueous phase was red.
Real-time PCR
Total RNA was isolated from cells using the RNeasy Mini kit (QIAGEN) ac-
cording to the manufacturer’s instructions. 1 µg of total RNA was used for 
cDNA synthesis, using the High Capacity cDNA Reverse Transcription kit 
(Applied Bioscience; Life Technologies) according to the manufacturer’s in-
structions. qRT-PCR was performed using the Brilliant SYBR Green qPCR 
Master Mix (600548; Agilent Technologies) and detected by the Mx3000P 
System (Agilent Technologies). The relative expression of each mRNA nor-
malized to the internal reference RPL13 was analyzed using the 2TC 
method (Butler and Mallampalli, 2010).
The primers used for real-time PCR were: ACSL1 forward, 5-GGG-
AAGAGCCAACAGACGGAAGC-3, and reverse, 5-CATATGGGCGAGA-
GGCAAGAAAGA-3. ACSL3 forward, 5-GGGACTTGGGAGGAGCT-
GTGTAAC-3, and reverse 5-CTCAATGTCCGCCTGGTAATGTGT-3. ACSL4 
forward, 5-GGGGCCCCGCTATCTCCTC-3, and reverse 5-CCTCTG-
GGGTTTGGCTTGTCAT-3. RPL13 forward, 5-ATGGCGGAGGGGCAG-
GTTCT-3, and reverse 5-CTCGGGAGGGGTTGGTATTCA-3.
In silico analysis of  helix formation
The in silico analysis of putative amphipathic helices in the amino acid se-
quence of HPos and human ACSL3 were predicted by the HELIQUEST pro-
gram (http://heliquest.ipmc.cnrs.fr/) according to the method previously 
published in Gautier et al. (2008).
Statistical analysis
All graphs correspond to the mean and standard deviation of at least three 
independent experiments. Statistical significances were determined using 
the Student’s t test; *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Online supplemental material
Fig. S1 (related to Fig. 5) includes a detailed colocalization between 
HPos and ACSL3, Plin 2, or Plin3. Fig. S2 (related to Fig. 7) compares 
the role of ACSL3 with ACSL1, ACSL4, and ACSL5 during LD assembly 
and neutral lipid accumulation. Fig. S3 (related to Fig. 7) demonstrates 
that the expression of an siRNA-resistant form of ACSL3 recovers the as-
sembly and accumulation of LDs inhibited after the siRNA of ACSL3. 
Fig. S4 (related to Fig. 7) shows that ACSL3 also regulates LD assembly 
and neutral lipid accumulation in hepatic cell lines. Fig. S5 (related to the 
Discussion) shows putative amphipathic  helices of HPos and ACSL3. 
Video 1 is related to Fig. 3 A and shows the biogenesis of LDs in the 
membranes of the ER. Videos 2 and 3 are related to Fig. 2 A and shows 
how pre-LDs and emerging LDs are loaded with a fluorescent fatty acid. 
Videos 4 and 5 show the tilting tomography of LDs detailed in Fig. 9. 
Also included is the code used to determine the number and size of ma-
ture LDs performed in Fig. 7 (Code areaMultipleImages-2.txt and instruc-
tions.doc). Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201305142/DC1.
Electron microscopy and tilting tomography
COS-1 cells cultured on carbon-coated sapphire discs were starved, treated 
with OA, and further incubated as described above. Cells were then fast-
frozen, freeze-substituted, and embedded in HM20 resin at low tempera-
ture (Nixon et al., 2009). 300-nm sections, nonspecifically labeled with 
gold as fiducial markers, were imaged using an intermediate voltage EM 
(Tecnai F30; FEI Company) operated at 300 kV, and motorized tilt-rotate 
specimen holders (models 650 and CT3500TR; Gatan, Inc.). Tilt series im-
ages (each 2,048 × 2,048 pixels) were digitally acquired with an Ultra-
Scan 4000 (USC4000, model 895; Gatan, Inc.). Dual-axis tilt series, 
collected over a total angular tilt range from 62° to +62° at 1° incre-
ments, were first aligned with one another by cross-correlation and subse-
quently by precisely tracking the positions of gold fiducials using the 
tiltalign program that is part of the imod software package (versions used: 
3.10.5–3.11.1; Richter et al., 2008).
Isolation of LDs
Two 10-cm dishes of COS-1 cells were transfected and treated as de-
scribed above. Cells were washed twice with cold PBS and resuspended 
in 500 µl of homogenization buffer (50 mmol/liter Tris-HCl, pH 7.5, 
150 mmol/ liter sodium chloride, and 5 mmol/ liter EDTA), supplemented 
with 10 µg/ml leupeptin and 10 µg/ml aprotinin. Cells were disrupted at 
4°C by nitrogen cavitation in a cell disruption bomb (ref. 46.39; Parr In-
strument Company) at 800 psi for 15 min and collected dropwise. After-
ward, cells were passed back and forth through a 22-gauge needle 
25 times at 4°C. Nuclei and unbroken cells were removed by centrifuga-
tion at 1,600 g in a MLA-130 rotor (Beckman Coulter) for 5 min at 4°C. 
The resulting supernatant (500 µl) was mixed with an equal volume of 2.5 M 
sucrose and loaded at the bottom of a discontinuous sucrose gradient 
formed by layers of 200 µl of 30, 25, 20, 15, 10, and 5% sucrose 
(wt/vol) freshly prepared in homogenization buffer. Gradients were centri-
fuged in a TLS-55 swinging-rotor (Beckman Coulter) without brake at 
166,000 g for 3 h at 4°C. Five fractions of 280 µl were collected from the 
top in addition to a final lower fraction of 700 µl by using a CentriTube 
Slicer (Beckman Coulter). The gradients shown in the figures are represen-
tative of at least two independent experiments.
Flow cytometry analysis
To determine neutral lipid accumulation after treatments, cells were trypsin-
ized, washed in PBS, and stained with Nile red (Gubern et al., 2008). 
Samples were analyzed by flow cytometry in a FACS CantoII equipped 
with a 488-nm argon laser and a 635-nm red diode laser (BD). Yellow 
emission of Nile red, corresponding to the neutral lipid staining, was 
measured in the 585/42 filter set. To determine neutral lipid content in 
GFP-transfected cells, after the treatments, cells were trypsinized, washed 
in PBS, and fixed in 4% PFA for 30 min. Cells were stained with LipidTOX 
Deep Red Neutral Lipid Stain (1:10,000; Life Technologies) and analyzed 
by flow cytometry. Deep Red emission of LipidTOX was measured in the 
660/20 filter set. For the staining of cells transfected with myc-ACSL3, cells 
were trypsinized, washed in PBS, and fixed in 4% PFA for 1 h, followed by 
saponin permeabilization (0.1% in PBS) for 10 min. After a 10-min incuba-
tion in 0.2% BSA, cells were labeled with anti-myc antibody (1:250) for 
1 h at room temperature in blocking solution, followed by incubation with 
secondary antibody goat anti–mouse Alexa Fluor 647. To analyze neutral 
lipid content, these cells were stained with BODIPY 493/503 (Bulankina 
et al., 2009) and analyzed by flow cytometry; green emission of BODIPY 
493/503 was measured in the 530/30 filter set and far red emission of 
Alexa Fluor 647 in the 660/20 filter set. The use of BODIPY 493/503 in 
the case of transfected cells was to avoid the interference of the Nile red 
emission with the far-red emission of the secondary antibody, as Nile red 
also has red fluorescence when it is solved in a phospholipid-rich environ-
ment (Greenspan et al., 1985).
Fluorescent thin layer chromatography
Cells treated with OA and BODIPY-FLC16 for the indicated times were 
trypsinized and resuspended in 600 µl of methanol/chloroform (1:2), then 
250 µl of chloroform and 250 µl of water were added and the solution 
was mixed by vortex (Bligh and Dyer, 1959). After a spin, the organic 
phase was collected, dried, resuspended with chloroform, and spotted 
onto 60 Å silica gel TLC plates (Partisil LK6D; Whatman) and dried for sev-
eral minutes. A solvent system of hexane/diethyl ether/acetic acid (70:30:1) 
was added to the TLC chamber and allowed to equilibrate, and plates 
were run until the solvent front reached 1 cm from the top of the plate. After 
drying, plates were scanned (ImageQuantT LAS4000 biomolecular im-
ager; GE Healthcare) using the blue fluorescence light (excitation, 460 nm; 
emission, Y515Di filter) to detect fluorescent bands.
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Figure S1.  Detailed colocalization between the proteins analyzed in this study. This figure is a supplement to Fig. 5. (A) Cells were cotransfected with GFP-
HPos and myc-ACSL3 and starved for 24 h (left) or additionally treated with OA for 15 min (right). (B) Endogenous ACSL3 was detected with a specific an-
tibody in starved HPos-transfected cells (left) and in cells additionally treated with OA for 7.5 min (right). The figure shows that the transfected and the 
endogenous ACSL3 completely colocalized with HPos in pre- and emerging LDs. (C and D) Endogenous Plin2 (red in C) and Plin3 (red in D) were detected 
with specific antibodies in starved HPos-transfected cells (left) and in cells additionally treated with OA for 15 min (right). Plin2 and Plin3 demonstrate only 
partial colocalization with HPos; the green arrows indicate colocalization and the red arrows indicate pre-LDs and emerging LDs that are HPos positive but 
Plin negative. Altogether, these results suggest that ACSL3 is earlier than Plin proteins on emerging LDs. Bars: (left) 25 µm; (insets) 0.5 µm; (right) 5 µm. 
(E) To test if Plin2 is present in a different subpopulation of LDs that exclude ACSL3, endogenous Plin3 (red) and endogenous ACSL3 (blue) were detected 
with specific antibodies, and the LDs were labeled with BODIPY 493/503 (green) in starved cells (left) and in cells additionally treated with OA for 15 min 
(right). White arrows indicate the structures that are positive for Plin3 but negative for ACSL3 and BODIPY and thus that are not LDs. Red arrows indicate 
again that some LDs contain ACSL3 but not Plin3. Bars, 2 µm.
JCB S2 
Figure S2.  Role of other ACSL family members in LD assembly and neutral lipid accumulation. This figure is a supplement to Fig. 7. (A) The relative expres-
sion levels of ACSL3 in the cell lines used in this study (see hepatic cells in Fig. S4) was compared with the expression of other ACSL family members by 
qRT-PCR (the value of ACSL3 in each cell line was normalized to 1). (B and C) COS-1 cells were transfected for 24 h with the siRNA corresponding to 
ACSL1, ACSL3, or ACSL4 and then additionally starved for 24 h. The percentage of RNA expression levels of each isoform at this time point, with respect 
to a nonrelated siRNA (nr), was determined by real-time PCR (B), and the specificity of each siRNA for the corresponding family member confirmed by 
Western blotting of cell homogenates (C). (D and E) Next, neutral lipids were quantified with Nile red and flow cytometry in the siRNA-transfected cells 
after the starvation period and after an additional treatment with OA for 1 h (D) or 24 h (E). **, P < 0.01. (F–I) To demonstrate that only ACSL3 determines 
LD levels, even when the ACSL enzymes are expressed to identical levels, COS-1 cells were transfected with the indicated GFP-tagged ACSL isoforms or 
with the GFP and starved for 24 h. Cells were then treated with OA for 30 min (F and G) or 16 h (H and I). LDs were labeled using LipidTOX Deep red, 
and the transfected cells were identified in the flow cytometer by the presence of green fluorescence. The graphs in F and H show the mean intensity of LDs 
(red fluorescence) in transfected cells (GFP positive), quantified in three independent experiments and normalized to the red fluorescence of unloaded GFP-
transfected cells. The graphs in G and I show a representative trend line of the red fluorescence (LD levels) quantified in cells with increasing levels of expres-
sion of each GFP-ACSL (green fluorescence intensity). Altogether, these results demonstrate that ACSL3 is the family member that determines biogenesis and 
accumulation of LDs in COS-1 cells. Error bars indicate the standard deviation of at least three independent experiments.
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Figure S3.  siRNA rescue experiment and the likely scaffolding role of ACSL3 during LD biogenesis. This figure is a supplement to Fig. 7. (A) Schematic rep-
resentation of the proteins used in the figure; an siRNA-resistant form of ACSL3 (ACSL3R) and an inactive form of ACSL3 generated by deletion of the resi-
dues corresponding to the Gate domain (ACSL3Gate). Although no conclusive structural information is available for the mammalian acyl-CoA synthetases 
(Soupene and Kuypers, 2008), in the specific case of ACSL6, the fatty acid Gate domain motif is essential for the activity of the human isoform (Soupene et 
al., 2010). Because this region is conserved in mammalian ACSLs, we generated a GFP-tagged ACSL3 without the Gate domain (red letters in Fig. S5 B). 
(B and C) The acyl-CoA synthetase activity was quantified in control COS-1 cells and in cells additionally transfected with ACSL3R or ACSL3Gate. In 
contrast to the full-length GFP-ACSL3, the GFP-ACSL3Gate did not demonstrate detectable enzymatic activity (B), although the expression of both proteins 
was similar when analyzed by Western blotting of cell homogenates with anti-GFP antibodies (C). (D and E) To rule out off-target effects of the siRNAs used 
in this study, starved ACSL3-depleted cells, by means of the siRNA, were transfected for 24 h with ACSL3R and then incubated for 45 min or 16 h with OA. 
Neutral lipids were labeled with Nile red and analyzed by confocal microscopy (D) or with LipidTOX and flow cytometry (E). The expression of ACSL3R 
rescued the inhibition caused by the siRNA of ACSL3 in the assembly and accumulation of LDs. The insets show representative emerging and mature LDs, 
and the asterisks indicate the transfected cells. (F and G) Finally, starved ACSL3Gate-transfected cells were also incubated for 45 min or 16 h with OA, 
and neutral lipids were stained with Nile red and analyzed by microscopy (F) or with LipidTOX and flow cytometry (G). After 45 min, the ACSL3Gate-
transfected cells demonstrated an increased accumulation of LDs when compared with cells transfected with GFP, which was similar to the increment caused 
by the full-length GFP-tagged ACSL3. The ACSL3Gate-expressing cells also demonstrated a relative increase in neutral lipid accumulation when treated 
with OA for 16 h. This lends support to the hypothesis that not only the enzymatic activity of ACSL3 but also other properties of the enzyme cooperate dur-
ing LD nucleation, and that the activity of the enzyme is involved in LD growth and expansion (see Discussion). The GFP-ACSL3Gate showed a preferential 
accumulation in one side of the LDs (high-magnification insets in F), which suggests that the fatty acid Gate domain partially determines the transport of the 
enzyme into LDs. White asterisks indicate transfected cells. Bars: (main panels) 25 µm; (insets) 2 µm. Error bars indicate the standard deviation of at least 
three independent experiments.
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Figure S4.  ACSL3 regulates LD assembly and neutral lipid accumulation in hepatic cell lines. This figure is a supplement to Fig. 7. To analyze the role of 
ACSL3 during LD formation and accumulation in other cell lines, we tested the effect of the ACSLs siRNA in human hepatic cell lines, such as HuH7 and 
HepG2. (A–C) First, GFP-HPos–transfected HuH7 (A and C) and HepG2 (B) cells were starved for 48 h. Distributions of HPos (green) and endogenous Plin2 
(red) were analyzed by confocal microscopy. The images show that the starvation conditions that efficiently removed LDs in COS-1 cells did not completely 
eliminate the presence of LDs in hepatic cells even when prolonged for 48 h. In contrast to the pre-LDs of COS-1 cells, the number of LDs observed in hepatic 
cells after starvation was partially reduced by Triacsin C or Platensimycin, a specific inhibitor of the fatty acid synthase (not depicted), which suggests that 
during starvation these LDs are supplied with newly synthesized fatty acids. After 48 h of starvation, HPos formed a characteristic ring around mature LDs 
that colocalized with endogenous Plin2 (A, B, and green arrows in C). The red arrows indicate HPos-positive but Plin2-negative structures. Thus, several 
structures positive for HPos and negative for Plin2, which could be equivalent to the pre-LDs observed in COS-1 cells, are also present in hepatic cells (C, 
red arrows). The insets show a representative mature LD. Bars: (A and B) 25 µm; (insets) 0.5 µm; (C) 2 µm. (D) To analyze lipid packaging in these cells, 
OFP-HPos–transfected HuH7 cells were treated as in Fig. 4 with the FA-BODIPY for 15 min. Cells were fixed, and lipid distribution was analyzed by micros-
copy. The green arrows indicate that the FA-BODIPY was rapidly packed in the small HPos-positive LDs and in the mature LDs. Bar, 2 µm. (E–K) To study the 
role of ACSL3 during lipid packaging, HuH7 and HepG2 cells were transfected for 24 h with the siRNAs corresponding to ACSL1, ACSL3, ACSL4, or 
ACSL5 and then additionally starved for 24 h. The RNA levels after each siRNA were measured by real-time PCR (A and B) and shown in the graph as a 
percentage with respect to cells transfected with a nonrelated siRNA (nr). The ACSL3 protein levels were additionally analyzed by Western blotting of cell 
homogenates (G). The cells were then loaded for 1 h or 24 h with OA, neutral lipids were stained with Nile red, and cellular fluorescence was quantified 
by flow cytometry. Only when ACSL3, but not other family members, was down-regulated were the early accumulation of neutral lipids and the long-term 
accumulation of LDs significantly reduced, which suggests that ACSL3 is the family member that regulates LD formation and accumulation in hepatic cell 
lines. Error bars indicate the standard deviation of at least three independent experiments. **, P < 0.01.
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Figure S5.  Putative amphipathic  helices in HPos and ACSL3. This figure is a supplement to the Discussion section. The figure shows the amino acid se-
quence and the in silico analysis of putative amphipathic  helices predicted by the HELIQUEST program (http://heliquest.ipmc.cnrs.fr/) to be formed by 
HPos and the human form of ACSL3 (three representative sequences; Gautier et al., 2008). In each helix, the hydrophobic amino acids (yellow) are en-
riched on the opposite side to negative (red) and positive (blue) residues.
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Video 1.  Starved GFP-HPos–transfected COS-1 cells were treated with cycloheximide for 30 min. This video corresponds to 
Fig. 3 A. Images were analyzed by time-lapse confocal microscopy using a laser scanning confocal spectral microscope (TCS 
SP5; Leica) equipped with an incubation control system (37°C, 5% CO2). Cells were selected for the labeling of well-defined 
tubular ER elements. In starved cells, pre-LDs were followed for 5 min (images were captured every 1.3 s). Next, OA (175 
µg/ml) was added (indicated with OA in left bottom corner) and images were captured for an additional 15 min every 9 s.
Video 2.  Images of starved COS-1 cells transfected with orange-HPos (red) were analyzed by time-lapse confocal microscopy 
using a laser scanning confocal spectral microscope (TCS SP5; Leica) equipped with an incubation control system (37°C, 5% 
CO2). This video corresponds to Fig. 2 A (merged channels). Cells were selected for the labeling of well-defined tubular ER ele-
ments. In starved cells, pre-LDs were followed for 5 min (images were captured every 1.3 s). Cells were then loaded with OA 
(175 µg/ml) that additionally contained a BODIPY-tagged fatty acid (1 µM, green). Images were captured for an additional 
15 min every 9 s.
Video 3.  The  three  channels  (merge  channels,  red  for HPos,  and green  for  FA-BODIPY)  of  two  selected pre-LDs and one 
emerging LD shown in Video 2. This video corresponds to Fig. 2 A (separated channels). As in Video 2, starved COS-1 cells 
transfected with orange-HPos (red) were analyzed using a laser-scanning confocal spectral microscope (TCS SP5; Leica). Cells 
were selected for the labeling of well-defined tubular ER elements. In starved cells, pre-LDs were followed for 5 min (images were 
captured every 1.3 s). Cells were then loaded with OA (175 µg/ml) that additionally contained a BODIPY-tagged fatty acid (1 
µM, green). Images were captured for an additional 15 min every 9 s.
Video 4.  Starved COS-1 cells were treated for 10 min with OA and then submitted to a second starvation for an additional 
16 h. This video corresponds to Fig. 9. Cells were processed with no primary fixative and a very quick nonperturbing freeze 
substitution protocol. 300-nm HM20 sections, nonspecifically labeled with gold as fiducial markers, were tilted ±60° in both 
axes, taking images every 1 or 2° using an intermediate-voltage EM (Tecnai F30; FEI Company). Bars, 250 nm.
Video 5.  Starved COS-1 cells were treated for 10 min with OA and then submitted to a second starvation for an additional 
16 h. This video corresponds to Fig. 9. Cells were processed with no primary fixative and a very quick nonperturbing freeze 
substitution protocol. 300-nm HM20 sections, nonspecifically labeled with gold as fiducial markers, were tilted ±60° in both 
axes taking images every 1 or 2° using an intermediate voltage EM (Tecnai F30; FEI Company). Bars, 250 nm.
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